E

ExeVir

19 employees

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Life Science

Date founded

2020

Funding rounds raised

Total raised

$49M

from 9 investors over 9 rounds

E

ExeVir raised $27M on January 9, 2023

Investors: European Investment Bank

E

ExeVir raised $49M on July 28, 2020

Investors: SRIW, Vives Louvain Technology Fund, -, FundPlus, -, UCB Ventures, VIB and V-Bio Ventures

FAQ